Table A
Predicted, sex-specific, five-year age-standardized net survival (NS) estimates by standard weight source used,^{Table A Note †} selected cancer type, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 2012 to 2014^{Table A Note ‡}

Table A
Predicted, sex-specific, five-year age-standardized net survival (NS) estimates by standard weight source used,&dagger selected cancer type, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 2012 to 2014‡
Table summary
This table displays the results of Predicted. The information is grouped by Cancer (appearing as row headers), Canadian cancer survival standard weights, International Cancer Survival Standard weights, Both sexes, Male, Female, NS (%) and 95% confidence interval, calculated using from and to units of measure (appearing as column headers).
Cancer	Canadian cancer survival standard weights									International Cancer Survival Standard weights
	Both sexes			Male			Female			Both sexes			Male			Female
	NS (%)	95% confidence interval		NS (%)	95% confidence interval		NS (%)	95% confidence interval		NS (%)	95% confidence interval		NS (%)	95% confidence interval		NS (%)	95% confidence interval
	NS (%)	from	to	NS (%)	from	to	NS (%)	from	to	NS (%)	from	to	NS (%)	from	to	NS (%)	from	to
Tongue	63	61	65	62	59	64	65	61	68	59	57	62	59	55	62	61	57	65
Esophagus	15	14	16	14	13	16	18	16	21	15	14	17	15	13	16	19	16	22
Stomach	28	27	29	27	25	28	30	28	32	29	28	30	28	26	29	31	29	33
Small intestine	56	54	59	56	52	59	56	53	60	56	53	58	56	52	59	56	52	60
Colon	65	64	65	65	64	66	65	64	66	66	65	67	66	65	67	66	65	67
Rectum	66	65	67	65	64	66	67	66	69	66	65	67	65	64	66	67	66	69
Anus	64	61	67	61	56	65	66	63	70	62	58	65	59	53	64	64	60	67
Liver	19	18	20	18	17	19	23	20	26	19	18	21	18	17	20	23	20	26
Pancreas	8	7	9	7	6	8	9	8	10	10	9	11	9	8	10	12	11	13
Larynx	62	59	64	62	60	65	57	52	62	62	59	65	63	60	66	58	52	63
Lung and bronchus	19	18	19	15	15	16	22	21	22	20	20	21	17	17	18	23	23	24
Soft tissue (including heart)	61	59	63	60	57	63	62	58	65	64	62	66	63	60	65	65	62	68
Melanomas of the skin	88	87	88	85	83	86	91	90	92	89	88	89	86	85	87	92	91	93
Breast	88	88	89	82	76	87	88	88	89	88	87	88	81	75	86	88	87	88
Cervix uteri	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	72	70	73	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	66	64	68
Uterus (body, NOS)	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	83	83	84	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	81	80	82
Ovary	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	45	44	46	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	41	39	42
Prostate	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	93	92	93	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	92	92	92	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable
Testis	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	97	96	97	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable	93	88	96	Note ...: not applicable	Note ...: not applicable	Note ...: not applicable
Bladder (including in situ)^{Table A Note §}	75	74	75	75	74	76	73	72	75	77	77	78	78	77	79	76	75	78
Kidney and renal pelvis	71	70	72	70	68	71	73	71	74	69	68	70	69	67	70	71	69	73
Brain	20	19	21	19	18	21	22	20	23	26	25	27	25	23	26	28	26	29
Thyroid	98	97	98	95	93	96	99	98	99	96	96	97	93	91	94	98	97	99
Hodgkin lymphoma	86	84	87	85	82	87	87	85	89	85	84	87	85	82	87	87	84	89
Non-Hodgkin lymphoma	68	67	69	66	65	67	71	69	72	69	68	69	66	65	68	71	70	72
Multiple myeloma	44	42	45	43	41	45	45	43	48	48	46	49	47	45	49	50	47	52
Chronic lymphocytic leukemia	83	81	84	80	78	82	87	84	89	85	83	86	82	80	84	88	86	90
Acute myeloid leukemia	20	18	21	19	17	21	20	18	23	19	18	21	19	17	21	20	18	22
Chronic myeloid leukemia	59	56	62	58	54	62	61	57	65	59	56	62	58	54	62	61	57	65
Mesothelioma	8	6	10	7	5	9	15	9	22	11	8	13	11	8	14	17	11	23
... not applicable Note † Canadian weights derived on a cancer-specific basis using Canadian Cancer Registry incidence data from 2010 to 2014 (see Analytical techniques). International weights were previously developed from incidence data collected for the EUROCARE-2 study (i.e., European patients diagnosed in the 1985-to-1989 period).20 Return to note † referrer Note ‡ data from Quebec have not been submitted to the Canadian Cancer Registry since the 2010 data year; NS estimates predicted using the period method Return to note ‡ referrer Note § the province of Ontario did not submit in situ bladder cancer cases to the Canadian Cancer Registry prior to the 2010 data year Return to note § referrer NOS=not otherwise specified; Sources: Canadian Cancer Registry death linked file (1992-2014); life tables.

Date modified:: 2018-10-03

Language selection

Search and menus

Search

Table A
Predicted, sex-specific, five-year age-standardized net survival (NS) estimates by standard weight source used,^{Table A Note †} selected cancer type, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 2012 to 2014^{Table A Note ‡}

Table A Predicted, sex-specific, five-year age-standardized net survival (NS) estimates by standard weight source used,Table A Note † selected cancer type, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 2012 to 2014Table A Note ‡

Note of appreciation

Standards of service to the public

Copyright

Table A
Predicted, sex-specific, five-year age-standardized net survival (NS) estimates by standard weight source used,^{Table A Note †} selected cancer type, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 2012 to 2014^{Table A Note ‡}